Literature DB >> 27617969

Functions, Regulation, and Therapeutic Implications of the ATR Checkpoint Pathway.

Stephanie A Yazinski1, Lee Zou1,2.   

Abstract

The ATR (ATM and rad3-related) pathway is crucial for proliferation, responding to DNA replication stress and DNA damage. This critical signaling pathway is carefully orchestrated through a multistep process requiring initial priming of ATR prior to damage, recruitment of ATR to DNA damage lesions, activation of ATR signaling, and, finally, modulation of ATR activity through a variety of post-translational modifications. Following activation, ATR functions in several vital cellular processes, including suppression of replication origin firing, promotion of deoxynucleotide synthesis and replication fork restart, prevention of double-stranded DNA break formation, and avoidance of replication catastrophe and mitotic catastrophe. In many cancers, tumor cells have increased dependence on ATR signaling for survival, making ATR a promising target for cancer therapy. Tumor cells compromised in DNA repair pathways or DNA damage checkpoints, cells reliant on homologous recombination, and cells with increased replication stress are particularly sensitive to ATR inhibition. Understanding ATR signaling and modulation is essential to unraveling which tumors have increased dependence on ATR signaling as well as how the ATR pathway can best be exploited for targeted cancer therapy.

Entities:  

Keywords:  ATR; Chk1; DNA damage; DNA repair; cancer therapy; checkpoint; genomic instability; replication stress

Mesh:

Substances:

Year:  2016        PMID: 27617969     DOI: 10.1146/annurev-genet-121415-121658

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  71 in total

1.  Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer.

Authors:  Yuping Yin; Qian Shen; Peng Zhang; Ruikang Tao; Weilong Chang; Ruidong Li; Gengchen Xie; Weizhen Liu; Lihong Zhang; Prabodh Kapoor; Shumei Song; Jaffer Ajani; Gordon B Mills; Jianying Chen; Kaixiong Tao; Guang Peng
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 2.  The DNA damage response pathway in normal hematopoiesis and malignancies.

Authors:  Domenico Delia; Shuki Mizutani
Journal:  Int J Hematol       Date:  2017-07-13       Impact factor: 2.490

3.  Differentiation of MISSLA and Fanconi anaemia by computer-aided image analysis and presentation of two novel MISSLA siblings.

Authors:  Magdalena Danyel; Zhuo Cheng; Christine Jung; Felix Boschann; Jean Tori Pantel; Nurulhuda Hajjir; Ricarda Flöttmann; Solveig Schulz; Ilja Demuth; Eamonn Sheridan; Stefan Mundlos; Denise Horn; Martin A Mensah
Journal:  Eur J Hum Genet       Date:  2019-07-18       Impact factor: 4.246

4.  CARM1 regulates replication fork speed and stress response by stimulating PARP1.

Authors:  Marie-Michelle Genois; Jean-Philippe Gagné; Takaaki Yasuhara; Jessica Jackson; Sneha Saxena; Marie-France Langelier; Ivan Ahel; Mark T Bedford; John M Pascal; Alessandro Vindigni; Guy G Poirier; Lee Zou
Journal:  Mol Cell       Date:  2021-01-06       Impact factor: 17.970

5.  ATR Protects the Genome against R Loops through a MUS81-Triggered Feedback Loop.

Authors:  Dominick A Matos; Jia-Min Zhang; Jian Ouyang; Hai Dang Nguyen; Marie-Michelle Genois; Lee Zou
Journal:  Mol Cell       Date:  2019-11-07       Impact factor: 17.970

6.  A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation.

Authors:  Lilian Kabeche; Hai Dang Nguyen; Rémi Buisson; Lee Zou
Journal:  Science       Date:  2017-11-23       Impact factor: 47.728

7.  Genotoxicity of tetrahydrofolic acid to hematopoietic stem and progenitor cells.

Authors:  Clara B García-Calderón; José Antonio Bejarano-García; Isabel Tinoco-Gago; María José Castro; Paula Moreno-Gordillo; José I Piruat; Teresa Caballero-Velázquez; José A Pérez-Simón; Iván V Rosado
Journal:  Cell Death Differ       Date:  2018-03-06       Impact factor: 15.828

8.  Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy.

Authors:  Yong Fang; Daniel J McGrail; Chaoyang Sun; Marilyne Labrie; Xiaohua Chen; Dong Zhang; Zhenlin Ju; Christopher P Vellano; Yiling Lu; Yongsheng Li; Kang Jin Jeong; Zhiyong Ding; Jiyong Liang; Steven W Wang; Hui Dai; Sanghoon Lee; Nidhi Sahni; Imelda Mercado-Uribe; Tae-Beom Kim; Ken Chen; Shiaw-Yih Lin; Guang Peng; Shannon N Westin; Jinsong Liu; Mark J O'Connor; Timothy A Yap; Gordon B Mills
Journal:  Cancer Cell       Date:  2019-06-10       Impact factor: 31.743

9.  The DNA Pol ϵ stimulatory activity of Mrc1 is modulated by phosphorylation.

Authors:  Zhong-Xin Zhang; Jingjing Zhang; Qinhong Cao; Judith L Campbell; Huiqiang Lou
Journal:  Cell Cycle       Date:  2017-12-21       Impact factor: 4.534

10.  Ca2+-Stimulated AMPK-Dependent Phosphorylation of Exo1 Protects Stressed Replication Forks from Aberrant Resection.

Authors:  Shan Li; Zeno Lavagnino; Delphine Lemacon; Lingzhen Kong; Alessandro Ustione; Xuewen Ng; Yuanya Zhang; Yingchun Wang; Bin Zheng; Helen Piwnica-Worms; Alessandro Vindigni; David W Piston; Zhongsheng You
Journal:  Mol Cell       Date:  2019-04-30       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.